Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neuraxis (NRXS) Return on Equity (2023 - 2025)

Historic Return on Equity for Neuraxis (NRXS) over the last 3 years, with Q3 2025 value amounting to 2.15%.

  • Neuraxis' Return on Equity fell 44200.0% to 2.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.15%, marking a year-over-year decrease of 44200.0%. This contributed to the annual value of 21.55% for FY2024, which is 235900.0% down from last year.
  • According to the latest figures from Q3 2025, Neuraxis' Return on Equity is 2.15%, which was down 44200.0% from 2.94% recorded in Q2 2025.
  • In the past 5 years, Neuraxis' Return on Equity ranged from a high of 5.79% in Q4 2023 and a low of 52.89% during Q4 2024
  • In the last 3 years, Neuraxis' Return on Equity had a median value of 1.2% in 2023 and averaged 5.51%.
  • The largest annual percentage gain for Neuraxis' Return on Equity in the last 5 years was 10700bps (2024), contrasted with its biggest fall of -586900bps (2024).
  • Neuraxis' Return on Equity (Quarter) stood at 5.79% in 2023, then plummeted by -1013bps to 52.89% in 2024, then surged by 96bps to 2.15% in 2025.
  • Its Return on Equity was 2.15% in Q3 2025, compared to 2.94% in Q2 2025 and 6.6% in Q1 2025.